NCT02202941已完成不适用
Effect of Procalcitonin-guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients in Korea
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 6
- 主要终点
- Duration of antibiotic treatment
研究概览
简要总结
This clinical trial is aimed to show a procalcitonin-guided treatment algorithm may shorten duration of antibiotic therapy safely and cost-effectively in sepsis patients of Korean ICU.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients with suspicious or confirmed sepsis at admission or during stay in ICU
- •Patients with antibiotic duration of less than 48 hours before enrollment
排除标准
- •Age less than or equal to 18 years
- •Known pregnancy
- •Specific infections for which long-term antibiotic treatment for 3 weeks more is strongly recommended: infective endocarditis, empyema, osteomyelitis et al.
- •severe immunocompromised patients : HIV infected patients (CD4 count < 200 cells/mm3), Neutropenia (ANC count < 500/mm3)
- •Presence of do-not-resuscitate order
研究组 & 干预措施
Procalcitonin guided treatment
Experimental
Patients who will be randomized to this arm will receive antibiotics therapy based on procalcitonin-guided algorithm.
干预措施: Procalcitonin guided treatment (Other)
Conventional treatment
Active Comparator
Patients who will be randomized to this arm will receive antibiotic therapy based on conventional practice.
干预措施: Conventional treatment (Other)
结局指标
主要结局
Duration of antibiotic treatment
时间窗: up to 28 days
次要结局
- Clinical response to treatment for infection(up to 28 days)
- In hospital mortality(up to 90 days)
- All cause mortality(up to 28 days)
- In ICU mortality(up to 28 days)
研究者
Sang-Min Lee
Associate professor
Seoul National University Hospital
研究点 (6)
Loading locations...
相似试验
Unknown
3 期
Procalcitonin to Shorten Antibiotics Duration in ICU PatientsSepsisNCT01379547National Taiwan University Hospital1,700
已完成
不适用
Procalcitonin Use in Pneumonia Patients in the Critical Care SettingPneumoniaNCT01788488Mayo Clinic134
已完成
不适用
Procalcitonin guided reduction of the duration of antibiotic therapy in Community Acquired PneumoniaCommunity Acquired Pneumonia (CAP)RespiratoryPneumoniaISRCTN04176397niversity Hospital Basel (Switzerland)250
已完成
不适用
Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile NeutropeniaFebrile NeutropeniaNCT00928291Federal University of Minas Gerais60
终止
不适用
Reduction the Duration of Antibiotic Therapy in the Elderly (PROPAGE)Lung InfectionNCT02173613University Hospital, Grenoble117
